Mirati Therapeutics


Mirati Therapeutics Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones.






Org chart

James Christensen
EVP, Chief Scientific Officer
John Moriarty
Chief Legal Officer
Peter Lee
Chief Compliance Officer
Susan Welsh
Chief Safety Officer
Maggie Ryan Laughlin
Sr Director, Human Resources Business Partner, Head Of Learning & Development
Lauren Schroeder
Senior Director Of Marketing For Market Access, Value & Patient Support
Vanessa Tassell
VP, Clinical Science
Charlie Jones
Regional Medical Affairs Director
Debbie Ryan
Director, Medical Strategy
Bill Paxton M.D. Fcap
Senior Medical Director
Mason Israel
Regional Medical Affairs Director
Shilpen Patel
Executive Medical Director, Mirati Therapeutics, Acquired By Bristol Myers Squibb
Kelly Pearson
Senior Associate Scientist
Alex Pennock
Associate Director End User Experience
Jim Shanley
Head Of Quality
Katie McGinn
Director, Quality Assurance
Mario Guzman
Associate Director Quality Assurance
Mehrdad Kheiripour
Senior Director, Product Development, CMC
Bifeng D.
Associate Director, Biostatistics
Jing He
Director Biostatistics
Alexas Williamson
Human Resource Information System Manager
Jennifer Colon
Senior Talent Acquisition Partner
Mike Dwyer
Director, Finance & Business Development
Paul Stephensen
Sr. Director, Financial Planning & Analysis
Corey Pecoraro
Senior Accounting Manager
Barry Lennon
Senior Director, Facilities
Maika Adair
Associate Director, External Manufacturing - Supply Chain
Romel Montellano
Senior Director, Regulatory Operations